Request a Proposal
Globe Offices 2017 Offices

Product lifecycle solutions

We deliver intelligent insights through the pharmaceutical product lifecycle

Lifecycle Diagram TM
From early-stage commercial opportunity assessment and market understanding, forecasting and landscaping, through ideation, concept testing, product and brand development, profiling, communications testing, launch and post-launch tracking, we can support pharma with intelligent market research and consulting solutions through the lifecycle of the brand.

- Drug opportunity assessment »
- Understanding the global market »
- Developing the product offering »
- Developing a pharmaceutical brand »
- Brand launch and beyond »

We promise:

Senior level involvement

Our large, senior team of over 40 Directors are involved at every stage of the project.

High quality research

Our outputs answer the key business questions with a clear, direct recommendation, supported by the research evidence.

Communication and flexibility

We keep clients informed through weekly updates and respond quickly to needs and deadlines.

A creative approach

We offer custom approaches, not branded solutions, so our research design is always creative and fresh.

Qualitative excellence »

  • Some example case studies
    Wargaming in HCV

    The challengeOur client had a product ready for launch in the HCV landscape. A number of new competitor products were expected to alter the market dynamics. Given the stage of development of both our client’s product and the competitors, a number of different scenarios could have played out. Consequently, the company wanted to conduct research in order to feed into strategy development for their product.…

    read more »
    Patient Assistance Programme Evaluation for Cardiovascular Conditions

    The challengeOur client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product. The client wanted to understand how successful the PAP was at meeting the needs of patients, trainers and prescribers, and whether it positively differentiated them from competitors. They wanted to evaluate each individual component…

    read more »
    Multiple Sclerosis new medical device research

    The challengeOur client wanted to find out how best to develop an implantable delivery device with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a device would be accepted by HCPs and patients. We also needed to identify the perceived benefit to stakeholders and offer ideas on how to optimize the device offering through the look of the…

    read more »
  • Our latest white papers
    South Korea: The next global player?

    In this paper, we will explore some of the key trends and outlooks for South Korea in more detail, including what lies behind its presence at the extremes of two conflicting global health indicators: longest life expectancy and highest suicide rates.

    read more »
    Will gene therapies finally be commercially viable to pharma?

    Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when attempting to develop this technology. We review gene therapy’s chequered past, look at recent developments in this field and consider the future for gene therapies on their way to market.

    read more »
    Understanding the chronic disease patient journey in emerging markets

    In this paper, we explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these rapidly changing and diverse regions.

    read more »